Generic Kaletra is not yet available. As soon as the patents for the individual components of the medication expire in December 2015, several companies are expected to begin producing generic versions of it. Until an approved version is actually available, do not purchase any so-called "generic Kaletra," because these products are potentially fake, substandard, and dangerous.
Generic Kaletra: An Overview
Kaletra® (
lopinavir and ritonavir) is a prescription
AIDS and
HIV medication. It belongs to a class of medications known as protease inhibitors. It actually contains two different protease inhibitors: lopinavir and
ritonavir. Ritonavir is used to increase the level of lopinavir in the blood, helping it work better.
Kaletra is made by Abbott Laboratories. It is currently under the protection of patents that prevent any generic Kaletra from being manufactured in the United States. Yet, if you search the Internet for "generic Kaletra," you may find a number of companies selling it. The fact is that these medicines may be fake, substandard, and potentially dangerous. Generic Kaletra may be available from another country, but there is really no way of knowing if you are getting genuine Kaletra. You should not buy any generic Kaletra until there is an approved version available.
When Will Generic Kaletra Be Available?
The first patent for lopinavir (one of the medications in Kaletra) currently expires in December 2015. The patents for the other component of Kaletra (ritonavir) expire earlier. December 2015 is most likely the earliest possible date that a generic version of Kaletra could become available. However, other circumstances could come up to extend the exclusivity period beyond 2015. This could include such things as other patents for specific
Kaletra uses or lawsuits. Once Kaletra goes off-patent, several companies will likely begin manufacturing a generic Kaletra drug.
Add this article to your Favorites
Email this article
Print